 TUCSON, Ariz., Sept. 23, 2021 PRNewswire -- Accelerate Diagnostics, Inc. Nasdaq: AXDX today announced that it has entered into separate, privately negotiated exchange agreements with certain holders of its 2.50 Convertible Senior Notes due 2023 the Notes. 